SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 730.00
+6.00 (0.83%)
Jul 15, 2026, 3:30 PM JST
SUSMED,Inc. Market Cap
SUSMED,Inc. has a market cap or net worth of 12.27 billion as of July 15, 2026. Its market cap has increased by 18.31% in one year.
Market Cap
12.27B
Enterprise Value
8.32B
Revenue
274.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
730.00
Market Cap Chart
Since December 24, 2021, SUSMED,Inc.'s market cap has decreased from 28.30B to 12.27B, a decrease of -56.63%. That is a compound annual growth rate of -16.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 12.27B | -13.51% |
| Dec 30, 2025 | 14.19B | 39.27% |
| Dec 30, 2024 | 10.19B | -54.23% |
| Dec 29, 2023 | 22.26B | 16.38% |
| Dec 30, 2022 | 19.13B | -41.83% |
| Dec 30, 2021 | 32.88B | 16.21% |
| Dec 24, 2021 | 28.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 18.80B |
| CanBas | 14.47B |
| RaQualia Pharma | 12.47B |
| ReproCELL | 12.26B |
| Stella Pharma | 11.75B |
| Kubota Pharmaceutical Holdings | 10.27B |
| Immuno-Biological Laboratories | 9.26B |
| CellSeed | 8.81B |